DrugPatentWatch Database Preview
Janssen R And D Company Profile
Email this page to a colleague
What is the competitive landscape for JANSSEN R AND D, and when can generic versions of JANSSEN R AND D drugs launch?
JANSSEN R AND D has two approved drugs.
There is one US patent protecting JANSSEN R AND D drugs.
There are fifty-five patent family members on JANSSEN R AND D drugs in thirty-five countries and twelve supplementary protection certificates in eleven countries.
Summary for Janssen R And D
| International Patents: | 55 |
| US Patents: | 1 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Janssen R And D
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-002 | Dec 22, 2010 | AB | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | ||||
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-003 | Mar 26, 2012 | RX | Yes | No | 7,037,917*PED | ⤷ Try it Free | ⤷ Try it Free | ||||
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-002 | Dec 22, 2010 | AB | RX | Yes | Yes | 7,037,917*PED | ⤷ Try it Free | ⤷ Try it Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Janssen R And D
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-003 | Mar 26, 2012 | 6,878,717*PED | ⤷ Try it Free |
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-001 | Jan 18, 2008 | 7,887,845*PED | ⤷ Try it Free |
| Janssen R And D | INTELENCE | etravirine | TABLET;ORAL | 022187-001 | Jan 18, 2008 | 7,037,917*PED | ⤷ Try it Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Janssen R And D Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Germany | 122009000003 | ⤷ Try it Free |
| European Patent Office | 1002795 | ⤷ Try it Free |
| Germany | 69941934 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Janssen R And D Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1002795 | SZ 5/2009 | Austria | ⤷ Try it Free | PRODUCT NAME: ETRAVIRIN UND DESSEN ADDITIONSSALZE |
| 1002795 | C01002795/01 | Switzerland | ⤷ Try it Free | PRODUCT NAME: ETRAVIRIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 58483 13.05.2008 |
| 1002795 | PA2008016 | Lithuania | ⤷ Try it Free | PRODUCT NAME: ETRAVIRINUM; REG. NO/DATE: EU/1/08/468/001 20080828 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
